PSS22 - Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

Saved in:

Bibliographic Details
Published in	Value in health Vol. 16; no. 7; p. A505
Main Authors	Leteneux, C., Claxton, L., Malcolm, W.A., Taylor, M., Rathi, H.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.11.2013
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015 1524-4733
DOI:	10.1016/j.jval.2013.08.1162